Digital tools in pharmacovigilance are increasingly valued for their transformative potential. Integrating these tools requires a strategic approach merging technological capability with regulatory compliance. A new key player, focusing on pharmacovigilance and digitalization, links software developers and traditional PV departments, ensuring innovations are viable, safe, and compliant for a seamless digital transformation.
Have look at the poster that ASPHALION experts Vanesa Palau, Ana Zambrano, Paula Sanz and Sonia López prepared for the World Drug Safety Congress 2025 about “The new key player in Digital Transformation and Pharmacovigilance”.
For further information, feel free to contact us at: [email protected]
Have a look at the poster here: Asphalion_WDSC_2025_The new key player in Digital transformation and pharmacovigilance
